OBJECTIVE	To investigate whether retinyl palmitate ( RP ) alone or plus beta-carotene ( BC ) would be as effective and less toxic than low-dose 13-cis retinoic acid ( 13cRA ) in treating oral premalignant lesions ( OPLs ) and reducing the risk of oral cancer .\